drugset / Trial / NCT00768261
Corticolimbic Degeneration and Treatment of Dementia
Phase 4
Completed
39 enrolled
Washington University School of Medicine
Northwestern University · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The overall purpose of this research is to determine if there is a relationship between your symptoms of Dementia of the Alzheimers type and changes in the size and shape of certain brain structures during combined Donepezil (Aricept®) and Memantine (Namenda®) treatment.
Timeline
- Start
- 2004-11
- Primary completion
- 2009-10
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Donepezil | Small molecule | 10 mg | — |
| Comparator | Memantine | Unknown | 20 mg | — |